|

HN2302 Injection Clinical Trials

1 actively recruiting trial

Also known as: in vivo CAR-T

Top Sponsors

  • The Affiliated Hospital of Xuzhou Medical University1

Indications

  • Refractory Myasthenia Gravis1
  • Cancer1

Other1 trial

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.